logo
Select company
Select metric
Ticker Information

Ticker

GRCE

Company Name

GRACE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GRACE THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GRCE - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -12.78M0%$ 0
3/31/2025$ -12.76M0%$ 0
12/31/2024$ -16.92M0%$ 0
9/30/2024$ -15.07M0%$ 0
6/30/2024$ -14.51M0%$ 0
3/31/2024$ -15.59M0%$ 0
12/31/2023$ -48.89M0%$ 0
9/30/2023$ -50.13M0%$ 0
6/30/2023$ -51.55M0%$ 0
3/31/2023$ -51.85M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for GRACE THERAPEUTICS INC is calculated as follows: EBITDA [ $ -17.79M ] / Revenues [ $ 0 ]
(=) EBITDA % [ 0% ]

GRCE - EBITDA Margin, Last 5 years

-19216.91%

Minimum

Dec 31, 2020

-3950.51%

Maximum

Sep 30, 2021

-9137.34%

Average

-7395.41%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.2% with a standard deviation of 26.73%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-74.33%
max97.24%
average16.2%
median14.74%
std26.73%